Oligometastatic head and neck cancer: Comprehensive review

T Vengaloor Thomas, S Packianathan, E Bhanat… - Head & …, 2020 - Wiley Online Library
There are limited data available regarding the management of oligometastatic squamous
cell carcinoma of the head and neck (SCCHN) patients, and no consensus guidelines are …

Use of multi-site radiation therapy for systemic disease control

RR Patel, V Verma, HB Barsoumian, MS Ning… - International Journal of …, 2021 - Elsevier
Metastatic cancer is a heterogeneous entity, some of which could benefit from local
consolidative radiation therapy (RT). Although randomized evidence is growing in support of …

[HTML][HTML] Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: a multi-institutional pooled analysis

JC Hong, DN Ayala-Peacock, J Lee, AW Blackstock… - PloS one, 2018 - journals.plos.org
Background Radiotherapy is increasingly used to treat oligometastatic patients. We sought
to identify prognostic criteria in oligometastatic patients undergoing definitive …

Stereotactic ablative radiation therapy for pulmonary metastases: histology, dose, and indication matter

J Helou, I Thibault, I Poon, A Chiang, S Jain… - International Journal of …, 2017 - Elsevier
Purpose To assess the association between colorectal cancer (CRC) histology, dose, and
local failure (LF) after stereotactic ablative radiation therapy (SABR) for pulmonary …

Potent half-sandwich Ru (Ⅱ) N^ N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities

Z Xu, J Huang, D Kong, Y Yang, L Guo, X Jia… - European Journal of …, 2020 - Elsevier
Herein a new series of organometallic half-sandwich Ru (Ⅱ) complexes bearing aryl-BIAN
chelating ligands with various electron-withdrawing and electron-donating substituents have …

Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases

NH Lester-Coll, AP Dosoretz, WJ Magnuson… - Journal of …, 2016 - thejns.org
OBJECTIVE The JLGK0901 study found that stereotactic radiosurgery (SRS) is a safe and
effective treatment option for treating up to 10 brain metastases. The purpose of this study is …

Concern over cost of and access to cancer treatments: a meta-narrative review of nivolumab and pembrolizumab studies

CRP da Veiga, CP da Veiga… - Critical reviews in …, 2018 - Elsevier
Background A better understanding of the modulation of the immune system has resulted in
the development of new classes of antitumor agents such as nivolumab and …

Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung

TMJ Kang, N Hardcastle, AK Singh, BJ Slotman… - Lung Cancer, 2022 - Elsevier
Stereotactic ablative radiotherapy (SABR) is a well-established treatment for patients with
medically inoperable early-stage non-small cell lung cancer (NSCLC) and pulmonary …

[HTML][HTML] Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from …

M Kissel, I Martel-Lafay, J Lequesne, JC Faivre… - BMC cancer, 2019 - Springer
Background Stereotactic irradiation (SBRT) is a standard of care for inoperable stage I lung
cancer and brain oligometastases from lung cancer but is controversial for extracranial …

The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?

JC Hong, JK Salama - Cancer Treatment Reviews, 2017 - Elsevier
The spectrum hypothesis posits that there are distinct clinical states of metastatic
progression. Early data suggest that aggressive treatment of more biologically indolent …